Physician
Hilltop Primary Care, INC
Hilltop Primary Care, INC was paid $589K by Medicaid between Jan 2018 and Dec 2024, across 33 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 56% of everything it billed.
33Billing provider infoHILLTOP PRIMARY CARE, INC
PHELPS, KY 41553
PHELPS, KY 41553
33aNPI1124084488assigned 04/25/2006
33bProvider typeFamily Medicine Physician
28Total paid$589K
24GClaims29,469
24DCodes billed33
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Kentucky
Rank by total paid#84 of 352
Median peer was paid$90K
This provider vs. median6.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,594 | $65K | |
| 2019 | 4,307 | $61K | |
| 2020 | 4,118 | $72K | |
| 2021 | 5,446 | $123K | |
| 2022 | 4,493 | $98K | |
| 2023 | 3,482 | $73K | |
| 2024incomplete | 4,029 | $97K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 56% | 13,242 | 10,709 | $331K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 13% | 1,934 | 1,647 | $75K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.0% | 1,396 | 1,186 | $30K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.7% | 656 | 572 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.7% | 1,739 | 1,466 | $28K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.0% | 1,182 | 716 | $18K |
| 99490 | Ccm add 20min | 2.2% | 564 | 556 | $13K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.2% | 1,052 | 960 | $13K |
| 36415 | Collection of venous blood by venipuncture | 1.8% | 2,480 | 2,285 | $11K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.7% | 274 | 262 | $10K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.7% | 578 | 477 | $10K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1.1% | 370 | 303 | $6K |
21 more codes
| 99439 | <1% | 190 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 123 | $3K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 241 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 39 | $2K |
| 90674 | <1% | 105 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 135 | $1K |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 59 | $727.57 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 87 | $436.80 |
| 87807 | <1% | 35 | $363.59 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 59 | $334.55 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 30 | $230.71 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 74 | $218.06 |
| 80305 | <1% | 17 | $128.78 | |
| 97802 | <1% | 16 | $105.02 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 17 | $46.35 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 1,711 | $14.39 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 20 | $8.58 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 799 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 138 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 91 | $0.00 |
| G8938 | Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARRIS, ZACH (CEO)